1B-LSD Blotter Unit (125 ug)
1-Butanoyl-d-lysergic acid diethylamide Hemi-L-Tartrate
Molecular Formula: C24H31N3O2
Molecular Weight: 393.522 g·mol−1
Form: Hemi-L-tartrate
IUPAC: 1-Butanoyl-N,N-diethyl-6-methyl-9,10-didehydroergoline-8β-carboxamide
CAS: N/A
Material Data Safety Sheet: Available upon request
NMR: N/A
LCMS: N/A
1B-LSD (1-benzyl-LSD) is a synthetic psychedelic compound that belongs to the lysergamide family, structurally related to LSD. It is a derivative of LSD, created to provide similar psychedelic effects while potentially being legally distinct from LSD in some jurisdictions.
125 µg Blotters:
- 125 µg (micrograms) indicates the amount of 1B-LSD present in each blotter square. This dosage is typically effective in producing noticeable psychedelic effects.
- Blotters are small pieces of paper that have been infused with the 1B-LSD compound. Users usually place the blotter under their tongue (sublingually) for absorption.
Effects:
The effects of 1B-LSD are believed to be similar to those of LSD, including:
- Visual hallucinations (enhanced colors, patterns)
- Altered perception of time
- Euphoria and mood enhancement
- Changes in thought processes and creativity
- Introspective experiences
The onset of effects typically occurs within 30 to 90 minutes after ingestion, peaking around 2 to 5 hours, and lasting approximately 8 to 12 hours overall.
As a research chemical, 1B-LSD has not been extensively studied, and its safety profile, long-term effects, and pharmacological details remain largely unknown. It is often marketed in areas where LSD is illegal, but users should check the legal status of 1B-LSD in their respective countries, as regulations can vary.
Relevant identified uses: For research use only, not for human or veterinary use
This research chemical is restricted in certain countries, region(s) and including individual states in USA. For some guidelines and more details please click here
